5-Iodo-2-aminoindane (5-IAI) is a drug which acts as a releasing agent of serotonin, norepinephrine, and dopamine. It was developed in the 1990s by a team led by David E. Nichols at Purdue University. 5-IAIfully substitutes for MDMA in rodents and is a putative entactogen in humans.
Aminoindans (AI) were originally studied as semi-rigid congeners of phenylethylamines. Which are psychoactive alkaloids.1,2 5-IAI is a psychoactive analog of p-iodoamphetamine and is indistinguishable. In its physiological effects, from 3,4-methylenedioxymethamphetamine in rats.3 A single 40 mg/kg dose of 5-IAI significantly reduces both serotonin uptake sites and hippocampal serotonin levels in rats.4 This product is intended for forensic applications.
Formal Name : 2,3-dihydro-5-iodo-1H-inden-2-amine, monohydrochloride
CAS Number : 1782044-60-3
Synonyms : 5-iodo-2-Aminoindane
Molecular Formula : C9H10IN • HCl
Formula Weight: 295.6
Formulation: A crystalline solid
InChI Code : InChI=1S/C9H10IN.ClH/c10-8-2-1-6-4-9(11)5-7(6)3-8;/h1-3,9H,4-5,11H2;1H
InChI Key : KXPCULLKBZKNFC-UHFFFAOYSA-N
Shipping: Wet ice in continental US; may vary elsewhere
Stability: ≥ 2 years